The global market size was valued at US$ 10.45 billion in 2024 and is projected to reach US$ 16.78 billion by 2030, at a CAGR of 8.2% during the forecast period 2024-2030.
The United States market size was valued at US$ 3.89 billion in 2024 and is projected to reach US$ 6.12 billion by 2030, at a CAGR of 7.9% during the forecast period 2024-2030.
Targeted therapies blocking vascular endothelial growth factor.
Treatment volume reached 8.5 million patients in 2023. Biosimilars grow at 9.5% annually. Market saw 48% increase in ophthalmology applications. Approvals obtained in 62 countries. Future investments of US$ 3.45 billion planned by 2026. North America leads with 44% market share.
Report Overview
Vascular endothelial growth factor inhibitors, also known as angiogenesis inhibitors, can prevent the generation of new blood vessels.
This report provides a deep insight into the global Vascular Endothelial Growth Factor (VEGF) Inhibitors market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Vascular Endothelial Growth Factor (VEGF) Inhibitors market in any manner.
Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Bayer AG
F. Hoffmann-La Roche Ltd.
Novartis AG
Regeneron Pharmaceuticals Inc.
Sanofi.
Market Segmentation (by Type)
VEGF-A Inhibitor
VEGF-B Inhibitor
VEGF-C Inhibitor
VEGF-D Inhibitor
Market Segmentation (by Application)
Oncology
Ophthalmology
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Vascular Endothelial Growth Factor (VEGF) Inhibitors Market
Overview of the regional outlook of the Vascular Endothelial Growth Factor (VEGF) Inhibitors Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Vascular Endothelial Growth Factor (VEGF) Inhibitors
1.2 Key Market Segments
1.2.1 Vascular Endothelial Growth Factor (VEGF) Inhibitors Segment by Type
1.2.2 Vascular Endothelial Growth Factor (VEGF) Inhibitors Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Overview
2.1 Global Market Overview
2.1.1 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Competitive Landscape
3.1 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales by Manufacturers (2019-2024)
3.2 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue Market Share by Manufacturers (2019-2024)
3.3 Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales Sites, Area Served, Product Type
3.6 Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Competitive Situation and Trends
3.6.1 Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Concentration Rate
3.6.2 Global 5 and 10 Largest Vascular Endothelial Growth Factor (VEGF) Inhibitors Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Vascular Endothelial Growth Factor (VEGF) Inhibitors Industry Chain Analysis
4.1 Vascular Endothelial Growth Factor (VEGF) Inhibitors Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Vascular Endothelial Growth Factor (VEGF) Inhibitors Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales Market Share by Type (2019-2024)
6.3 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Market Share by Type (2019-2024)
6.4 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Price by Type (2019-2024)
7 Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Sales by Application (2019-2024)
7.3 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (M USD) by Application (2019-2024)
7.4 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales Growth Rate by Application (2019-2024)
8 Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Segmentation by Region
8.1 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales by Region
8.1.1 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales by Region
8.1.2 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales Market Share by Region
8.2 North America
8.2.1 North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Bayer AG
9.1.1 Bayer AG Vascular Endothelial Growth Factor (VEGF) Inhibitors Basic Information
9.1.2 Bayer AG Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Overview
9.1.3 Bayer AG Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Market Performance
9.1.4 Bayer AG Business Overview
9.1.5 Bayer AG Vascular Endothelial Growth Factor (VEGF) Inhibitors SWOT Analysis
9.1.6 Bayer AG Recent Developments
9.2 F. Hoffmann-La Roche Ltd.
9.2.1 F. Hoffmann-La Roche Ltd. Vascular Endothelial Growth Factor (VEGF) Inhibitors Basic Information
9.2.2 F. Hoffmann-La Roche Ltd. Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Overview
9.2.3 F. Hoffmann-La Roche Ltd. Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Market Performance
9.2.4 F. Hoffmann-La Roche Ltd. Business Overview
9.2.5 F. Hoffmann-La Roche Ltd. Vascular Endothelial Growth Factor (VEGF) Inhibitors SWOT Analysis
9.2.6 F. Hoffmann-La Roche Ltd. Recent Developments
9.3 Novartis AG
9.3.1 Novartis AG Vascular Endothelial Growth Factor (VEGF) Inhibitors Basic Information
9.3.2 Novartis AG Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Overview
9.3.3 Novartis AG Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Market Performance
9.3.4 Novartis AG Vascular Endothelial Growth Factor (VEGF) Inhibitors SWOT Analysis
9.3.5 Novartis AG Business Overview
9.3.6 Novartis AG Recent Developments
9.4 Regeneron Pharmaceuticals Inc.
9.4.1 Regeneron Pharmaceuticals Inc. Vascular Endothelial Growth Factor (VEGF) Inhibitors Basic Information
9.4.2 Regeneron Pharmaceuticals Inc. Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Overview
9.4.3 Regeneron Pharmaceuticals Inc. Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Market Performance
9.4.4 Regeneron Pharmaceuticals Inc. Business Overview
9.4.5 Regeneron Pharmaceuticals Inc. Recent Developments
9.5 Sanofi.
9.5.1 Sanofi. Vascular Endothelial Growth Factor (VEGF) Inhibitors Basic Information
9.5.2 Sanofi. Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Overview
9.5.3 Sanofi. Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Market Performance
9.5.4 Sanofi. Business Overview
9.5.5 Sanofi. Recent Developments
10 Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Forecast by Region
10.1 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Forecast
10.2 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Forecast by Country
10.2.3 Asia Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Forecast by Region
10.2.4 South America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Vascular Endothelial Growth Factor (VEGF) Inhibitors by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Vascular Endothelial Growth Factor (VEGF) Inhibitors by Type (2025-2030)
11.1.2 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Vascular Endothelial Growth Factor (VEGF) Inhibitors by Type (2025-2030)
11.2 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Forecast by Application (2025-2030)
11.2.1 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales (Kilotons) Forecast by Application
11.2.2 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Comparison by Region (M USD)
Table 5. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vascular Endothelial Growth Factor (VEGF) Inhibitors as of 2022)
Table 10. Global Market Vascular Endothelial Growth Factor (VEGF) Inhibitors Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales Sites and Area Served
Table 12. Manufacturers Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Type
Table 13. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Vascular Endothelial Growth Factor (VEGF) Inhibitors
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Challenges
Table 22. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales by Type (Kilotons)
Table 23. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (M USD)
Table 24. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales (Kilotons) by Type (2019-2024)
Table 25. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales Market Share by Type (2019-2024)
Table 26. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (M USD) by Type (2019-2024)
Table 27. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Share by Type (2019-2024)
Table 28. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Price (USD/Ton) by Type (2019-2024)
Table 29. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales (Kilotons) by Application
Table 30. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application
Table 31. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales Market Share by Application (2019-2024)
Table 33. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales by Application (2019-2024) & (M USD)
Table 34. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Application (2019-2024)
Table 35. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales Growth Rate by Application (2019-2024)
Table 36. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales Market Share by Region (2019-2024)
Table 38. North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales by Region (2019-2024) & (Kilotons)
Table 43. Bayer AG Vascular Endothelial Growth Factor (VEGF) Inhibitors Basic Information
Table 44. Bayer AG Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Overview
Table 45. Bayer AG Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Bayer AG Business Overview
Table 47. Bayer AG Vascular Endothelial Growth Factor (VEGF) Inhibitors SWOT Analysis
Table 48. Bayer AG Recent Developments
Table 49. F. Hoffmann-La Roche Ltd. Vascular Endothelial Growth Factor (VEGF) Inhibitors Basic Information
Table 50. F. Hoffmann-La Roche Ltd. Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Overview
Table 51. F. Hoffmann-La Roche Ltd. Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. F. Hoffmann-La Roche Ltd. Business Overview
Table 53. F. Hoffmann-La Roche Ltd. Vascular Endothelial Growth Factor (VEGF) Inhibitors SWOT Analysis
Table 54. F. Hoffmann-La Roche Ltd. Recent Developments
Table 55. Novartis AG Vascular Endothelial Growth Factor (VEGF) Inhibitors Basic Information
Table 56. Novartis AG Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Overview
Table 57. Novartis AG Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Novartis AG Vascular Endothelial Growth Factor (VEGF) Inhibitors SWOT Analysis
Table 59. Novartis AG Business Overview
Table 60. Novartis AG Recent Developments
Table 61. Regeneron Pharmaceuticals Inc. Vascular Endothelial Growth Factor (VEGF) Inhibitors Basic Information
Table 62. Regeneron Pharmaceuticals Inc. Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Overview
Table 63. Regeneron Pharmaceuticals Inc. Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Regeneron Pharmaceuticals Inc. Business Overview
Table 65. Regeneron Pharmaceuticals Inc. Recent Developments
Table 66. Sanofi. Vascular Endothelial Growth Factor (VEGF) Inhibitors Basic Information
Table 67. Sanofi. Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Overview
Table 68. Sanofi. Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Sanofi. Business Overview
Table 70. Sanofi. Recent Developments
Table 71. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales Forecast by Region (2025-2030) & (Kilotons)
Table 72. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Forecast by Region (2025-2030) & (M USD)
Table 73. North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales Forecast by Country (2025-2030) & (Kilotons)
Table 74. North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Forecast by Country (2025-2030) & (M USD)
Table 75. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales Forecast by Country (2025-2030) & (Kilotons)
Table 76. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Forecast by Country (2025-2030) & (M USD)
Table 77. Asia Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales Forecast by Region (2025-2030) & (Kilotons)
Table 78. Asia Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Forecast by Region (2025-2030) & (M USD)
Table 79. South America Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales Forecast by Country (2025-2030) & (Kilotons)
Table 80. South America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Forecast by Country (2025-2030) & (M USD)
Table 81. Middle East and Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Consumption Forecast by Country (2025-2030) & (Units)
Table 82. Middle East and Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Forecast by Country (2025-2030) & (M USD)
Table 83. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales Forecast by Type (2025-2030) & (Kilotons)
Table 84. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Forecast by Type (2025-2030) & (M USD)
Table 85. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Price Forecast by Type (2025-2030) & (USD/Ton)
Table 86. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales (Kilotons) Forecast by Application (2025-2030)
Table 87. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Vascular Endothelial Growth Factor (VEGF) Inhibitors
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (M USD), 2019-2030
Figure 5. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (M USD) (2019-2030)
Figure 6. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (M USD)
Figure 11. Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales Share by Manufacturers in 2023
Figure 12. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue Share by Manufacturers in 2023
Figure 13. Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Vascular Endothelial Growth Factor (VEGF) Inhibitors Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Type
Figure 18. Sales Market Share of Vascular Endothelial Growth Factor (VEGF) Inhibitors by Type (2019-2024)
Figure 19. Sales Market Share of Vascular Endothelial Growth Factor (VEGF) Inhibitors by Type in 2023
Figure 20. Market Size Share of Vascular Endothelial Growth Factor (VEGF) Inhibitors by Type (2019-2024)
Figure 21. Market Size Market Share of Vascular Endothelial Growth Factor (VEGF) Inhibitors by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Application
Figure 24. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales Market Share by Application (2019-2024)
Figure 25. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales Market Share by Application in 2023
Figure 26. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Application (2019-2024)
Figure 27. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Application in 2023
Figure 28. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales Growth Rate by Application (2019-2024)
Figure 29. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales Market Share by Region (2019-2024)
Figure 30. North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales Market Share by Country in 2023
Figure 32. U.S. Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales Market Share by Country in 2023
Figure 37. Germany Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales Market Share by Region in 2023
Figure 44. China Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales and Growth Rate (Kilotons)
Figure 50. South America Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales Market Share by Country in 2023
Figure 51. Brazil Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share Forecast by Type (2025-2030)
Figure 65. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales Forecast by Application (2025-2030)
Figure 66. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share Forecast by Application (2025-2030)
